IBDEI1TP ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32540,1,4,0)
 ;;=4^R68.3
 ;;^UTILITY(U,$J,358.3,32540,2)
 ;;=^5019553
 ;;^UTILITY(U,$J,358.3,32541,0)
 ;;=R73.01^^190^1955^84
 ;;^UTILITY(U,$J,358.3,32541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32541,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,32541,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,32541,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,32542,0)
 ;;=R73.02^^190^1955^85
 ;;^UTILITY(U,$J,358.3,32542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32542,1,3,0)
 ;;=3^Impaired Glucose Tolerance (oral)
 ;;^UTILITY(U,$J,358.3,32542,1,4,0)
 ;;=4^R73.02
 ;;^UTILITY(U,$J,358.3,32542,2)
 ;;=^5019562
 ;;^UTILITY(U,$J,358.3,32543,0)
 ;;=R73.09^^190^1955^13
 ;;^UTILITY(U,$J,358.3,32543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32543,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,32543,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,32543,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,32544,0)
 ;;=R73.9^^190^1955^80
 ;;^UTILITY(U,$J,358.3,32544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32544,1,3,0)
 ;;=3^Hyperglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,32544,1,4,0)
 ;;=4^R73.9
 ;;^UTILITY(U,$J,358.3,32544,2)
 ;;=^5019564
 ;;^UTILITY(U,$J,358.3,32545,0)
 ;;=R76.11^^190^1955^136
 ;;^UTILITY(U,$J,358.3,32545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32545,1,3,0)
 ;;=3^Positive PPD
 ;;^UTILITY(U,$J,358.3,32545,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,32545,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,32546,0)
 ;;=R79.1^^190^1955^3
 ;;^UTILITY(U,$J,358.3,32546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32546,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,32546,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,32546,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,32547,0)
 ;;=R82.5^^190^1955^65
 ;;^UTILITY(U,$J,358.3,32547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32547,1,3,0)
 ;;=3^Elevated Urine Levels of Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,32547,1,4,0)
 ;;=4^R82.5
 ;;^UTILITY(U,$J,358.3,32547,2)
 ;;=^5019605
 ;;^UTILITY(U,$J,358.3,32548,0)
 ;;=R82.6^^190^1955^24
 ;;^UTILITY(U,$J,358.3,32548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32548,1,3,0)
 ;;=3^Abnormal Urine Levels of Subst of Nonmed Source
 ;;^UTILITY(U,$J,358.3,32548,1,4,0)
 ;;=4^R82.6
 ;;^UTILITY(U,$J,358.3,32548,2)
 ;;=^5019606
 ;;^UTILITY(U,$J,358.3,32549,0)
 ;;=R82.7^^190^1955^25
 ;;^UTILITY(U,$J,358.3,32549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32549,1,3,0)
 ;;=3^Abnormal Urine Microbiological Findings
 ;;^UTILITY(U,$J,358.3,32549,1,4,0)
 ;;=4^R82.7
 ;;^UTILITY(U,$J,358.3,32549,2)
 ;;=^5019607
 ;;^UTILITY(U,$J,358.3,32550,0)
 ;;=R82.8^^190^1955^21
 ;;^UTILITY(U,$J,358.3,32550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32550,1,3,0)
 ;;=3^Abnormal Urine Cytology/Histology Findings
 ;;^UTILITY(U,$J,358.3,32550,1,4,0)
 ;;=4^R82.8
 ;;^UTILITY(U,$J,358.3,32550,2)
 ;;=^5019608
 ;;^UTILITY(U,$J,358.3,32551,0)
 ;;=R82.90^^190^1955^23
 ;;^UTILITY(U,$J,358.3,32551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32551,1,3,0)
 ;;=3^Abnormal Urine Findings,Unspec
 ;;^UTILITY(U,$J,358.3,32551,1,4,0)
 ;;=4^R82.90
 ;;^UTILITY(U,$J,358.3,32551,2)
 ;;=^5019609
 ;;^UTILITY(U,$J,358.3,32552,0)
 ;;=R82.91^^190^1955^46
 ;;^UTILITY(U,$J,358.3,32552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32552,1,3,0)
 ;;=3^Chromoabnormalities of Urine NEC
 ;;^UTILITY(U,$J,358.3,32552,1,4,0)
 ;;=4^R82.91
 ;;^UTILITY(U,$J,358.3,32552,2)
 ;;=^5019610
 ;;^UTILITY(U,$J,358.3,32553,0)
 ;;=R82.99^^190^1955^22
 ;;^UTILITY(U,$J,358.3,32553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32553,1,3,0)
 ;;=3^Abnormal Urine Findings NEC
